Story perspectives

US Rejoins WHO for Critical Vaccine Discussions Amid Controversy

2/12/2026

Summary

Story summary

The United States will participate in a World Health Organization meeting later this month to discuss influenza vaccine compositions.
The United States departed the World Health Organization in January 2025, a move officials warned could harm public health.
Maria Van Kerkhove, WHO Director, emphasized the importance of global influenza surveillance.
Tedros Adhanom Ghebreyesus, WHO Director-General, called a United States-funded Guinea-Bissau hepatitis B vaccine study unethical.

1 of 1

Story summary

The United States will participate in a World Health Organization meeting later this month to discuss influenza vaccine compositions.
The United States departed the World Health Organization in January 2025, a move officials warned could harm public health.
Maria Van Kerkhove, WHO Director, emphasized the importance of global influenza surveillance.
Tedros Adhanom Ghebreyesus, WHO Director-General, called a United States-funded Guinea-Bissau hepatitis B vaccine study unethical.